Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

CVS - CVS Health - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1266501006

Health Insurance, Pharmacy Services, Prescription Drugs, Over-the-Counter Products

CVS Health Corporation is a leading healthcare company in the United States, dedicated to providing a range of health solutions to individuals, employers, and healthcare providers. The company operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.

The Health Care Benefits segment offers a diverse portfolio of health insurance products and services, catering to a broad range of customers, including employer groups, individuals, college students, and government-sponsored plans. This segment provides traditional, voluntary, and consumer-directed health insurance products, ensuring that individuals and groups have access to quality healthcare.

The Health Services segment is a pharmacy benefit management (PBM) solutions provider, offering a comprehensive suite of services to employers, insurance companies, unions, and government employee groups. These services include plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management. By leveraging its expertise in PBM, CVS Health helps its clients optimize their healthcare spending and improve health outcomes.

The Pharmacy & Consumer Wellness segment is a retail pharmacy business that sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment operates a network of online retail pharmacy websites, long-term care (LTC) pharmacies, on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies, and branches for infusion and enteral nutrition services. Additionally, it provides pharmacy consulting and ancillary services to care facilities and other care settings, supporting the healthcare needs of patients across various settings.

With a rich history dating back to 1996, CVS Health Corporation has evolved over the years, expanding its services and capabilities to become a leading healthcare company. In September 2014, the company changed its name from CVS Caremark Corporation to CVS Health Corporation, reflecting its commitment to providing a broader range of healthcare services. Headquartered in Woonsocket, Rhode Island, CVS Health Corporation continues to innovate and invest in its capabilities, driving better health outcomes and improving the overall healthcare experience for its customers.

Drawdown (Underwater) Chart

Overall Trend and Yearly Seasonality

CVS Stock Overview

Market Cap in USD	75,209m
Sector	Healthcare
Industry	Healthcare Plans
GiC SubIndustry	Health Care Services
TER	0.00%
IPO / Inception	1984-12-17

CVS Stock Ratings

Growth 5y	15.6
Fundamental	18.0
Dividend	64.9
Rel. Performance vs Sector	-2.63
Analysts	3.83/5
Fair Price Momentum	67.94 USD
Fair Price DCF	170.92 USD

CVS Dividends

Dividend Yield 12m	4.26%
Yield on Cost 5y	5.36%
Dividends CAGR 5y	3.89%
Payout Consistency	96.8%

CVS Growth Ratios

Growth 12m	-15.04%
Growth Correlation 12m	-16%
Growth Correlation 3m	23%
CAGR 5y	4.67%
CAGR/Mean DD 5y	0.30
Sharpe Ratio 12m	-0.67
Alpha vs SP500 12m	-32.13
Beta vs SP500 5y weekly	0.76
ValueRay RSI	75.90
Volatility GJR Garch 1y	26.00%
Price / SMA 50	4.77%
Price / SMA 200	-9.54%
Current Volume	14553.2k
Average Volume 20d	8686.7k

External Links for CVS Stock

News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle

What is the price of CVS stocks?
As of July 27, 2024, the stock is trading at USD 61.00 with a total of 14,553,173 shares traded.
Over the past week, the price has changed by +3.56%, over one month by +1.75%, over three months by -8.17% and over the past year by -15.13%.

What are the forecast for CVS stock price target?
According to ValueRays Forecast Model, CVS CVS Health will be worth about 73.4 in July 2025. The stock is currently trading at 61.00. This means that the stock has a potential upside of +20.3%.

Issuer	Forecast	Upside
Wallstreet Target Price	61.1	0.11
Analysts Target Price	90.2	47.8
ValueRay Target Price	73.4	20.3

Understanding CVS Health Corp: A Comprehensive Overview

History of CVS Health Corp

CVS Health Corp, originally named Consumer Value Stores, embarked on its journey in 1963, starting as a health and beauty products retailer in Lowell, Massachusetts. Over decades, it has evolved, marking milestones that shaped it into a frontline pharmacy innovation company. Key transformations include the introduction of pharmacy benefit management (PBM) services in 2007, further expansion into healthcare services, and the pivotal acquisition of Aetna in 2018. This expansion has cemented CVS's role in the healthcare ecosystem, moving beyond retail to become a holistic healthcare provider.

Core and Side Businesses

The core business of CVS Health encompasses its retail pharmacy services, which operate under the CVS Pharmacy brand, providing prescription medications, health products, and wellness goods. Additionally, it runs walk-in medical clinics known as MinuteClinic that offer treatments and vaccinations. A significant part of CVS's operations also lies in its healthcare benefits segment, managed under Aetna, catering to millions with health insurance products and services.

Beyond these, CVS Health is engaged in pharmacy benefit management (PBM) through CVS Caremark, optimizing prescription drug benefits on behalf of health insurers, employers, and government agencies. Its comprehensive approach also extends to specialty pharmacy services, focusing on chronic and genetic diseases' treatments. While these are the core segments, CVS continuously innovates in digital health and other side ventures aiming at enhancing overall healthcare accessibility and affordability.

Current Market Status

As of 2023, CVS Health Corp maintains a robust presence in the health care market, benefiting from a wide network of physical locations and an expanding array of health services. The company has adeptly navigated the challenges and opportunities presented by the global pandemic, accelerating its digital transformation and telehealth services. Its strategic acquisitions, like that of Aetna, continue to diversify its revenue streams and strengthen its market position against competitors. The financial performance demonstrates significant resilience and potential for growth, reflecting its adaptability and commitment to healthcare innovation.